publication venue for
- Advancing LBD Diagnosis: EEG Biomarkers for Cognitive Fluctuations 2025
- Developing Disease-duration Specific Percentiles for Prospective Subtyping of the Diffuse Malignant Parkinson's Disease: A PPMIbased study 2025
- Patterns and Predictors of Cholinesterase Inhibitor Use in Dementia with Lewy Bodies 2025
- Skin Biopsy for Phosphorylated α-Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice 2025
- Substantia Nigra Iron Deposition in Lewy Body Disease: A Magnetic Resonance Imaging and Neuropathology Study 2025
- Longitudinal Free-Water Changes in Dementia with Lewy Bodies 2024
- Optimizing Screening for Intrastriatal Interventions in Huntington's Disease Using Predictive Models 2024
- Subtyping Parkinson's disease (PD) Mild Cognitive Impairment (PD-MCI) by Cholinergic Degeneration 2024
- Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies 2022
- 18F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy 2019
- Does Transcranial Direct Current Simulation Improve Motor Functions in Patients with Parkinson's disease? 2019
- Reply to Letter: Basis of Cingulate Island Sign May Differ in Dementia With Lewy Bodies and Posterior Cortical Atrophy 2019
- Mavoglurant (AFQ056) for the Treatment of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease: A Pooled Analysis of 485 Patients' Data 2018
- Inhibiting sphingosine-1-phosphate lyase as a possible therapy in Huntington's disease 2017
- Istradefylline and Preladenant as adjuvant therapies for patients with Parkinson's disease 2017
- Meta-analysis of mortality following subthalamic and pallidal Deep Brain Stimulation for patients with Parkinson's disease 2017
- Arguing against the proposed definition changes of PD 2016
- Creatine for patients with Parkinson's disease: A meta-analysis 2016
- Gene delivery of AAV2-neurturin for patients with Parkinson's disease: A meta-analysis 2016
- Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry 2016
- Safety and efficacy of pardoprunox for patients with Parkinson's disease: A meta-analysis 2016